Medtronic To Distribute Viz.ai’s System For Identifying Strokes

Medtronic will distribute Viz.ai’s artificial intelligence system for detection and triage of large vessel occlusions in the US alongside Medtronic's Solitaire stent-retrievers for revascularization of occluded blood vessels in the brain.

abstract-network
• Source: shutterstock.com

Medtronic PLC has agreed to distribute Viz.ai Inc.’s artificial intelligence system for detection and triage of large vessel brain occlusion (LVO) strokes alongside its Solitaire stent retrievers, the companies announced July 22.

Viz.ai’s technology uses advanced artificial intelligence to identify suspected LVO strokes based on data from computed tomography (CT) data. It...

More from Business

Mexico’s New Procurement Rules Aim To Increase Healthcare Investment, But May Face Legal Trouble

 

Legal experts warn, however, that new Mexican procurement rules are discriminatory and could be challenged in the courts.

Will Kennedy And Makary Come To Terms On User Fees During Next Round Of MDUFA Negotiations?

 

It’s no secret that Marty Makary and Robert F. Kennedy Jr. have a different take on user fees, with Makary viewing them as a funding necessity and Kennedy as a corrupting influence. But will they find a way to strike a balance during the next MDUFA reauthorization talks so each can claim victory?

FDA Regulations ‘Lock Out’ Clinically Proven Neuromodulation Devices

 

Flow Neuroscience's neuromodulation headset for the treatment of depression is approved and marketed in the EU. However, two years on, the company is still waiting for US FDA approval despite being assigned breakthrough device designation.

UK MHRA Joins New Global Network For Safe Use Of AI In Healthcare

 

The UK's regulatory agency is the first to join a new international network for oversight of AI in healthcare run by a non-profit organization, HealthAI, the global agency for responsible AI in health.

More from Medtech Insight

EU Publishes Guidance On Interplay Between AI Act And Medtech Regulations

 

Overlapping clinical testing requirements and decision-making around significant changes to MDAI are among the tricky subjects that the new document explains.

Tarver And Makary Emphasize Commitment To At-Home Healthcare Innovations In FDA Podcast

 
• By 

FDA officials Michelle Tarver and Marty Makary discussed advancements in home healthcare during a podcast. They highlighted the importance of continuous glucose monitors, emphasized home healthcare's benefits for chronic diseases, and mentioned the agency's efforts to streamline device development.

UK MHRA Joins New Global Network For Safe Use Of AI In Healthcare

 

The UK's regulatory agency is the first to join a new international network for oversight of AI in healthcare run by a non-profit organization, HealthAI, the global agency for responsible AI in health.